[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100356377":3},{"organization":4,"armGroups":7,"interventions":29,"overallOfficials":38,"centralContacts":38,"locations":45,"responsibleParty":76,"collaborators":38,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":38,"eligibilityCriteria":84,"healthyVolunteers":85,"sex":86,"minAge":87,"maxAge":38,"enrollmentInfo":88,"targetDuration":38,"studyType":91,"phases":92,"briefSummary":95,"conditions":96,"keywords":38,"overallStatus":98,"whyStopped":38,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Oyster Point Pharma, Inc.","INDUSTRY",[8,14,19,24],{"label":9,"type":10,"description":11,"interventionNames":12},"OC-01 Low Dose, 0.12 mg\u002FmL","ACTIVE_COMPARATOR","OC-01 (varenicline) nasal spray, 0.12 mg\u002FmL",[13],"Drug: OC-01 Low Dose, 0.12 mg\u002FmL",{"label":15,"type":10,"description":16,"interventionNames":17},"OC-01 Mid Dose, 0.6 mg\u002FmL","OC-01 (varenicline) nasal spray, 0.60 mg\u002FmL",[18],"Drug: OC-01 Mid Dose, 0.6 mg\u002FmL",{"label":20,"type":10,"description":21,"interventionNames":22},"OC-01 High Dose, 1.2 mg\u002FmL","OC-01 (varenicline) nasal spray, 1.2 mg\u002FmL",[23],"Drug: OC-01 High Dose, 1.2 mg\u002FmL",{"label":25,"type":26,"description":25,"interventionNames":27},"Placebo (vehicle) nasal spray","PLACEBO_COMPARATOR",[28],"Drug: Placebo (vehicle) nasal spray",[30,36,39,43],{"type":31,"name":9,"description":32,"armGroupLabels":33,"otherNames":34},"DRUG","OC-01 (varenicline) nasal spray",[9],[35],"OC-01 (varenicline) nasal spray, 0.12 mg\u002Fml",{"type":31,"name":15,"description":32,"armGroupLabels":37,"otherNames":38},[15],null,{"type":31,"name":20,"description":32,"armGroupLabels":40,"otherNames":41},[20],[42],"OC-01 Mid Dose, 1.2 mg\u002FmL",{"type":31,"name":25,"description":25,"armGroupLabels":44,"otherNames":38},[25],[46,58,67],{"facility":47,"status":38,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":38},"Newport Beach","California","92663","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-117.92895,33.61891,{"lat":56,"lon":55},{"facility":59,"status":38,"city":59,"state":60,"zip":61,"country":50,"countryCode":51,"cosmosGeoPoint":62,"geoPoint":66,"contacts":38},"Indianapolis","Indiana","46290",{"type":53,"coordinates":63},[64,65],-86.15804,39.76838,{"lat":65,"lon":64},{"facility":68,"status":38,"city":68,"state":69,"zip":70,"country":50,"countryCode":51,"cosmosGeoPoint":71,"geoPoint":75,"contacts":38},"Andover","Massachusetts","01810",{"type":53,"coordinates":72},[73,74],-71.137,42.65843,{"lat":74,"lon":73},{"type":77,"investigatorFullName":38,"investigatorTitle":38,"investigatorAffiliation":38,"oldNameTitle":38,"oldOrganization":38},"SPONSOR","100356377","phase-2-evaluation-of-the-long-term-follow-up-of-the-efficacy-of-oc-01-nasal-spray-on-signs-and-symptoms-of-dry-eye-disease-100356377",true,"NCT03920215","Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease","Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET Study)-Long Term Safety Follow-up","Inclusion Criteria:\n\n1. Have been enrolled in the OPP-002 study\n2. Have received at least one dose of the study drug\u002Fplacebo in OPP-002 study\n3. Completed the OPP-002 study to Visit 5\n4. Have provided verbal and written informed consent\n\nExclusion Criteria:\n\n1\\. Have discontinued prior to Visit 5 in the OPP-002 study.",false,"ALL","22 Years",{"count":89,"type":90},101,"ACTUAL","INTERVENTIONAL",[93,94],"PHASE2","PHASE3","The objective of this safety long-term follow-up study was to evaluate the safety of OC-01 Nasal Spray at 6 months and 12 months post treatment in the OPP-002 study (NCT03636061).",[97],"Long Term Follow up Dry Eye Disease","COMPLETED","2023-10-30",{"date":101,"type":90},"2023-11-01",{"date":103,"type":90},"2018-08-15",{"date":105,"type":90},"2019-09-20",{"name":5,"class":6},3]